[1]
R. M. Rajagukguk, “USE OF SODIUM-GLUCOSE TRANSPORT PROTEIN 2 (SGLT2) INHIBITORS IN DIABETIC KIDNEY DISEASE (DKD)”, JARMHS, vol. 9, no. 4, pp. 46–52, Apr. 2023, doi: 10.53555/nnmhs.v9i4.1653.